Tasha Lea

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Mark S. Anderson, Chun Jimmie Ye, Gabriela K. Fragiadakis, 2022, Science immunology.

Preservation of fine‐needle aspiration specimens for future use in RNA‐based molecular testing

C. Dumur, C. Garrett, C. Powers, 2011, Cancer cytopathology.

Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19

Gabriela K. Fragiadakis, R. Dewar, A. Beagle, 2022, Critical Care.

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Erin L. Schenk, Sourav Bandyopadhyay, N. Neff, 2020, Cell.

A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression.

M. Moasser, H. Rugo, A. Goga, 2020 .

Heterogeneity and targeted therapy-induced adaptations in lung cancer revealed by longitudinal single-cell RNA sequencing

Erin L. Schenk, N. Neff, J. Weissman, 2019, bioRxiv.

Discovering dominant tumor immune archetypes in a pan-cancer census

E. Nakakura, A. Olshen, S. Asthana, 2021, Cell.

Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS

Kenneth T. Hu, Kamir J. Hiam, N. Neff, 2021, Nature Communications.